Natural Killer Cell Therapy Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (NK Cell Therapies, NK Cell Directed Antibodies), By Applications (Cancer, Gastrointestinal Diseases, Other), Regional Insights and Forecast to 2035
- Last Updated: 16-November-2026
- Base Year: 2025
- Historical Data: 2021 - 2024
- Region: Global
- Format: PDF
- Report ID: GGI100724
- SKU ID: 30467391
- Pages: 99
Download FREE Sample
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Natural Killer Cell Therapy Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Natural Killer Cell Therapy Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Natural Killer Cell Therapy Business Mode and Production Process
2.3.1 Natural Killer Cell Therapy Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Natural Killer Cell Therapy Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Natural Killer Cell Therapy
2.4.2 Raw Material Cost of Natural Killer Cell Therapy
2.4.3 Labor Cost of Natural Killer Cell Therapy
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Natural Killer Cell Therapy Revenue and Market Share by Manufacturer (2020-2026)
4.2 Global Natural Killer Cell Therapy Sales Volume and Market Share by Manufacturer (2020-2026)
4.3 Global Natural Killer Cell Therapy Price by Manufacturer (2020-2026)
4.4 Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Natural Killer Cell Therapy, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Natural Killer Cell Therapy, Product Offered and Application
4.7 Natural Killer Cell Therapy Market Competitive Situation and Trends
4.7.1 Natural Killer Cell Therapy Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Natural Killer Cell Therapy Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Natural Killer Cell Therapy Market Historical Development by Geographic Region (2020-2026)
5.1 Global Natural Killer Cell Therapy Market Historical Sales Volume by Geographic Region (2020-2026)
5.2 Global Natural Killer Cell Therapy Market Historical Revenue by Geographic Region (2020-2026)
5.3 North America Natural Killer Cell Therapy Market Status by Country (2020-2026)
5.3.1 North America Natural Killer Cell Therapy Sales Volume by Country (2020-2026)
5.3.2 North America Natural Killer Cell Therapy Revenue by Country (2020-2026)
5.3.3 United States Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.3.4 Canada Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4 Europe Natural Killer Cell Therapy Market Status by Country (2020-2026)
5.4.1 Europe Natural Killer Cell Therapy Sales Volume by Country (2020-2026)
5.4.2 Europe Natural Killer Cell Therapy Revenue by Country (2020-2026)
5.4.3 Germany Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.4 France Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.5 United Kingdom Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.6 Spain Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.7 Russia Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.8 Poland Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5 Asia Pacific Natural Killer Cell Therapy Market Status by Country (2020-2026)
5.5.1 Asia Pacific Natural Killer Cell Therapy Sales Volume by Country (2020-2026)
5.5.2 Asia Pacific Natural Killer Cell Therapy Revenue by Country (2020-2026)
5.5.3 China Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.4 Japan Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.5 South Korea Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.6 Southeast Asia Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.7 India Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.8 Australia Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.6 Latin America Natural Killer Cell Therapy Market Status by Country (2020-2026)
5.6.1 Latin America Natural Killer Cell Therapy Sales Volume by Country (2020-2026)
5.6.2 Latin America Natural Killer Cell Therapy Revenue by Country (2020-2026)
5.6.3 Mexico Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.6.4 Brazil Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.7 Middle East and Africa Natural Killer Cell Therapy Market Status by Country (2020-2026)
5.7.1 Middle East and Africa Natural Killer Cell Therapy Sales Volume by Country (2020-2026)
5.7.2 Middle East and Africa Natural Killer Cell Therapy Revenue by Country (2020-2026)
5.7.3 GCC Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
5.7.4 South Africa Natural Killer Cell Therapy Sales Volume, Revenue and Growth (2020-2026)
6 Global Natural Killer Cell Therapy Market Historical Development by Product Type (2020-2026)
6.1 Natural Killer Cell Therapy Definition by Type
6.2 Global Natural Killer Cell Therapy Historical Sales Volume by Product Type (2020-2026)
6.3 Global Natural Killer Cell Therapy Historical Revenue by Product Type (2020-2026)
6.4 Global Natural Killer Cell Therapy Historical Price by Product Type (2020-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2026)
6.5.1 Global Natural Killer Cell Therapy Historical Sales Volume, Revenue and Growth Rate of NK Cell Therapies (2020-2026)
6.5.2 Global Natural Killer Cell Therapy Historical Sales Volume, Revenue and Growth Rate of NK Cell Directed Antibodies (2020-2026)
7 Global Natural Killer Cell Therapy Market Historical Development by End User (2020-2026)
7.1 Downstream Market Overview
7.2 Global Natural Killer Cell Therapy Historical Sales Volume by End User (2020-2026)
7.3 Global Natural Killer Cell Therapy Historical Revenue by End User (2020-2026)
7.4 Global Natural Killer Cell Therapy Historical Price by End User (2020-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2026)
7.5.1 Global Natural Killer Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Cancer (2020-2026)
7.5.2 Global Natural Killer Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Gastrointestinal Diseases (2020-2026)
7.5.3 Global Natural Killer Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Other (2020-2026)
8 Leading Companies Profiles
8.1 NKT Therapeutics Inc.
8.1.1 NKT Therapeutics Inc. Corporation Information
8.1.2 NKT Therapeutics Inc. - Natural Killer Cell Therapy Product Portfolio and Specification
8.1.3 NKT Therapeutics Inc. Performance Analysis (2020-2026)
8.1.4 NKT Therapeutics Inc. Business and Markets Served
8.1.5 NKT Therapeutics Inc. Recent Developments
8.2 Ziopharm Oncology Inc.
8.2.1 Ziopharm Oncology Inc. Corporation Information
8.2.2 Ziopharm Oncology Inc. - Natural Killer Cell Therapy Product Portfolio and Specification
8.2.3 Ziopharm Oncology Inc. Performance Analysis (2020-2026)
8.2.4 Ziopharm Oncology Inc. Business and Markets Served
8.2.5 Ziopharm Oncology Inc. Recent Developments
8.3 Fortress Biotech
8.3.1 Fortress Biotech Corporation Information
8.3.2 Fortress Biotech - Natural Killer Cell Therapy Product Portfolio and Specification
8.3.3 Fortress Biotech Performance Analysis (2020-2026)
8.3.4 Fortress Biotech Business and Markets Served
8.3.5 Fortress Biotech Recent Developments
8.4 Innate Pharma S.A.
8.4.1 Innate Pharma S.A. Corporation Information
8.4.2 Innate Pharma S.A. - Natural Killer Cell Therapy Product Portfolio and Specification
8.4.3 Innate Pharma S.A. Performance Analysis (2020-2026)
8.4.4 Innate Pharma S.A. Business and Markets Served
8.4.5 Innate Pharma S.A. Recent Developments
8.5 Glycostem Therapeutics BV
8.5.1 Glycostem Therapeutics BV Corporation Information
8.5.2 Glycostem Therapeutics BV - Natural Killer Cell Therapy Product Portfolio and Specification
8.5.3 Glycostem Therapeutics BV Performance Analysis (2020-2026)
8.5.4 Glycostem Therapeutics BV Business and Markets Served
8.5.5 Glycostem Therapeutics BV Recent Developments
8.6 Celgene Corporation
8.6.1 Celgene Corporation Corporation Information
8.6.2 Celgene Corporation - Natural Killer Cell Therapy Product Portfolio and Specification
8.6.3 Celgene Corporation Performance Analysis (2020-2026)
8.6.4 Celgene Corporation Business and Markets Served
8.6.5 Celgene Corporation Recent Developments
8.7 Nantkwest Inc.
8.7.1 Nantkwest Inc. Corporation Information
8.7.2 Nantkwest Inc. - Natural Killer Cell Therapy Product Portfolio and Specification
8.7.3 Nantkwest Inc. Performance Analysis (2020-2026)
8.7.4 Nantkwest Inc. Business and Markets Served
8.7.5 Nantkwest Inc. Recent Developments
8.8 Affimed N.V.
8.8.1 Affimed N.V. Corporation Information
8.8.2 Affimed N.V. - Natural Killer Cell Therapy Product Portfolio and Specification
8.8.3 Affimed N.V. Performance Analysis (2020-2026)
8.8.4 Affimed N.V. Business and Markets Served
8.8.5 Affimed N.V. Recent Developments
8.9 Fate Therapeutics
8.9.1 Fate Therapeutics Corporation Information
8.9.2 Fate Therapeutics - Natural Killer Cell Therapy Product Portfolio and Specification
8.9.3 Fate Therapeutics Performance Analysis (2020-2026)
8.9.4 Fate Therapeutics Business and Markets Served
8.9.5 Fate Therapeutics Recent Developments
8.10 Nkarta Therapeutics, Inc.
8.10.1 Nkarta Therapeutics, Inc. Corporation Information
8.10.2 Nkarta Therapeutics, Inc. - Natural Killer Cell Therapy Product Portfolio and Specification
8.10.3 Nkarta Therapeutics, Inc. Performance Analysis (2020-2026)
8.10.4 Nkarta Therapeutics, Inc. Business and Markets Served
8.10.5 Nkarta Therapeutics, Inc. Recent Developments
9 Global Natural Killer Cell Therapy Market Forecast by Product Type and End User (2026-2035)
9.1 Global Natural Killer Cell Therapy Market Forecast by Product Type (2026-2035)
9.1.1 Global Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of NK Cell Therapies (2026-2035)
9.1.2 Global Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of NK Cell Directed Antibodies (2026-2035)
9.2 Global Natural Killer Cell Therapy Market Forecast by End User (2026-2035)
9.2.1 Global Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Cancer (2026-2035)
9.2.2 Global Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Gastrointestinal Diseases (2026-2035)
9.2.3 Global Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Other (2026-2035)
10 Global Natural Killer Cell Therapy Market Forecast by Geographic Region (2026-2035)
10.1 Global Natural Killer Cell Therapy Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Natural Killer Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
Download FREE Sample